{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:43:43Z","timestamp":1791150223425,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,9]]},"DOI":"10.7759\/cureus.85661","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:56:41Z","timestamp":1749527801000},"source":"Crossref","is-referenced-by-count":2,"title":["Incidence and Predictors of Drug-Induced Liver Injury in Pediatric Tuberculosis Patients Under Anti-tubercular Therapy: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Vasanthakumar","family":"Manokaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baljinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Allen Christa","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"I","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_382_23","article-title":"The prevalence of tuberculosis infection in India: a systematic review and meta-analysis","volume":"157","author":"Chauhan A","year":"2023","unstructured":"Chauhan A, Parmar M, Dash GC, et al.. The prevalence of tuberculosis infection in India: a systematic review and meta-analysis. Indian J Med Res. 2023, 157:135-51. 10.4103\/ijmr.ijmr_382_23","journal-title":"Indian J Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/783698","article-title":"Pediatric tuberculosis in young children in India: a prospective study","volume":"2013","author":"Jain SK","year":"2013","unstructured":"Jain SK, Ordonez A, Kinikar A, et al.. Pediatric tuberculosis in young children in India: a prospective study. Biomed Res Int. 2013, 2013:783698. 10.1155\/2013\/783698","journal-title":"Biomed Res Int"},{"key":"ref3","article-title":"National TB Prevalence Survey in India 2019-2021","author":"Indian Council of Medical Research","year":"2023","unstructured":"Indian Council of Medical Research. National TB Prevalence Survey in India 2019-2021. Indian Council of Medical Research (ICMR), New Delhi, India; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2020.09.028","article-title":"Latent TB (LTBI) treatment: challenges in India with an eye on 2025: \"to treat LTBI or not to treat, that is the question\"","volume":"67","author":"Rajpal S","year":"2020","unstructured":"Rajpal S, Arora VK. Latent TB (LTBI) treatment: challenges in India with an eye on 2025: \"to treat LTBI or not to treat, that is the question\". Indian J Tuberc. 2020, 67:S43-7. 10.1016\/j.ijtb.2020.09.028","journal-title":"Indian J Tuberc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.920350","article-title":"Drug-induced liver injury from anti-tuberculosis treatment: a retrospective cohort study","volume":"26","author":"Zhao H","year":"2020","unstructured":"Zhao H, Wang Y, Zhang T, Wang Q, Xie W. Drug-induced liver injury from anti-tuberculosis treatment: a retrospective cohort study. Med Sci Monit. 2020, 26:e920350. 10.12659\/MSM.920350","journal-title":"Med Sci Monit"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1406454","article-title":"Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury","volume":"15","author":"Liu Q","year":"2024","unstructured":"Liu Q, Huang L, Yan H, et al.. Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury. Front Pharmacol. 2024, 15:1406454. 10.3389\/fphar.2024.1406454","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-022-04317-7","article-title":"A prospective observational study of hepatic dysfunction in children on antitubercular drugs","volume":"89","author":"Mehra A","year":"2022","unstructured":"Mehra A, Semwal P, Bhat NK, Bolia R. A prospective observational study of hepatic dysfunction in children on antitubercular drugs. Indian J Pediatr. 2022, 89:1126-8. 10.1007\/s12098-022-04317-7","journal-title":"Indian J Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002433","article-title":"Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China","volume":"29","author":"Xu N","year":"2022","unstructured":"Xu N, Yang JX, Yang J. Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China. Eur J Hosp Pharm. 2022, 29:217-21. 10.1136\/ejhpharm-2020-002433","journal-title":"Eur J Hosp Pharm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa V","year":"2013","unstructured":"Ramappa V, Aithal GP. Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol. 2013, 3:37-49. 10.1016\/j.jceh.2012.12.001","journal-title":"J Clin Exp Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1256-y","article-title":"The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study","volume":"20","author":"Song JH","year":"2019","unstructured":"Song JH, Yoon SY, Park TY, Heo EY, Kim DK, Chung HS, Lee JK. The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study. Respir Res. 2019, 20:283. 10.1186\/s12931-019-1256-y","journal-title":"Respir Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-024-01643-w","article-title":"Incidence and risk factors of antituberculosis drug-induced liver injury in India: a systematic review and meta-analysis","volume":"44","author":"Kumar R","year":"2025","unstructured":"Kumar R, Kumar A, Patel R, Prakash SS, Kumar S, Surya H, Marrapu S. Incidence and risk factors of antituberculosis drug-induced liver injury in India: a systematic review and meta-analysis. Indian J Gastroenterol. 2025, 44:35-46. 10.1007\/s12664-024-01643-w","journal-title":"Indian J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3988","article-title":"Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study","volume":"25","author":"Sun Q","year":"2016","unstructured":"Sun Q, Zhang Q, Gu J, et al.. Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study. Pharmacoepidemiol Drug Saf. 2016, 25:908-17. 10.1002\/pds.3988","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2150131916642431","article-title":"Prevalence of hepatotoxicity from antituberculosis therapy: a five-year experience from south India","volume":"7","author":"Saha A","year":"2016","unstructured":"Saha A, Shanthi FXM, Winston AB, Das S, Kumar A, Michael JS, Balamugesh T. Prevalence of hepatotoxicity from antituberculosis therapy: a five-year experience from south India. J Prim Care Community Health. 2016, 7:171-4. 10.1177\/2150131916642431","journal-title":"J Prim Care Community Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14896","article-title":"Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): large cohort study involving 4652 Chinese adult tuberculosis patients","volume":"41","author":"Jiang F","year":"2021","unstructured":"Jiang F, Yan H, Liang L, et al.. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): large cohort study involving 4652 Chinese adult tuberculosis patients. Liver Int. 2021, 41:1565-75. 10.1111\/liv.14896","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4081\/pr.2011.e16","article-title":"Malnutrition and risk of antituberculosis drug-induced hepatotoxicity in children","volume":"58","author":"Singh P","year":"2021","unstructured":"Singh P, Das A, Gupta D, et al.. Malnutrition and risk of antituberculosis drug-induced hepatotoxicity in children. Indian Pediatr. 2021, 58:22-6. 10.4081\/pr.2011.e16","journal-title":"Indian Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0960327113512860","article-title":"Female gender as a susceptibility factor for drug-induced liver injury","volume":"33","author":"Amacher DE","year":"2014","unstructured":"Amacher DE. Female gender as a susceptibility factor for drug-induced liver injury. Hum Exp Toxicol. 2014, 33:928-39. 10.1177\/0960327113512860","journal-title":"Hum Exp Toxicol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2330-z","article-title":"Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK","volume":"17","author":"Abbara A","year":"2017","unstructured":"Abbara A, Chitty S, Roe JK, et al.. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK. BMC Infect Dis. 2017, 17:231. 10.1186\/s12879-017-2330-z","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074866","article-title":"Anti-tuberculosis drug-induced liver injury","volume":"383","author":"Lim WS","year":"2023","unstructured":"Lim WS, Avery A, Kon OM, Dedicoat M. Anti-tuberculosis drug-induced liver injury. BMJ. 2023, 383:e074866. 10.1136\/bmj-2023-074866","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2021-101886","article-title":"Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)","volume":"13","author":"Brennan PN","year":"2022","unstructured":"Brennan PN, Cartlidge P, Manship T, Dillon JF. Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI). Frontline Gastroenterol. 2022, 13:332-6. 10.1136\/flgastro-2021-101886","journal-title":"Frontline Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/livers3020013","article-title":"Principles of nutritional management in patients with liver dysfunction\u2014a narrative review","volume":"3","author":"Elsebaie EM","year":"2023","unstructured":"Elsebaie EM, Abdel-Fattah AN, Bakr NA, et al.. Principles of nutritional management in patients with liver dysfunction\u2014a narrative review. Livers. 2023, 3:190-218. 10.3390\/livers3020013","journal-title":"Livers"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpge.2015.06.004","article-title":"Nutrition in chronic liver disease","volume":"22","author":"Silva M","year":"2015","unstructured":"Silva M, Gomes S, Peixoto A, et al.. Nutrition in chronic liver disease. GE Port J Gastroenterol. 2015, 22:268-76. 10.1016\/j.jpge.2015.06.004","journal-title":"GE Port J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/489823","article-title":"Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure","volume":"2010","author":"B\u00e9meur C","year":"2010","unstructured":"B\u00e9meur C, Desjardins P, Butterworth RF. Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. J Nutr Metab. 2010, 2010:489823. 10.1155\/2010\/489823","journal-title":"J Nutr Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369977-incidence-and-predictors-of-drug-induced-liver-injury-in-pediatric-tuberculosis-patients-under-anti-tubercular-therapy-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:56:42Z","timestamp":1749527802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369977-incidence-and-predictors-of-drug-induced-liver-injury-in-pediatric-tuberculosis-patients-under-anti-tubercular-therapy-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.85661","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,9]]}}}